modelIohexol

Extends from Pharmacolibrary.Drugs.ATC.V.V08AB02.

Information

name:Iohexol
ATC code:V08AB02
route:intravenous
compartments:2
dosage:350mg
volume of distribution:0.26L
clearance:107mL/min
other parameters in model implementation

Iohexol is a non-ionic, water-soluble radiographic contrast agent commonly used in diagnostic imaging procedures such as computed tomography (CT) and angiography. It is typically administered intravenously and aids in the visualization of blood vessels and tissues. Iohexol is approved and widely used in clinical practice.

Pharmacokinetics

Pharmacokinetics in healthy adult volunteers after a single intravenous bolus injection; reported in a two-compartment model.

References

  1. Baklouti, S, et al., & Cagnardi, P (2021). Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling Time. Frontiers in pharmacology 12 634404–None. DOI:10.3389/fphar.2021.634404 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33995036

  2. Djerada, Z, et al., & Malinovsky, JM (2014). Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response. British journal of clinical pharmacology 77(6) 1027–1038. DOI:10.1111/bcp.12291 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24252055

  3. Carrier, P, et al., & Loustaud-Ratti, V (2022). Iohexol plasma and urinary concentrations in cirrhotic patients: A pilot study. World journal of hepatology 14(8) 1621–1632. DOI:10.4254/wjh.v14.i8.1621 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36157874

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)